Read by QxMD icon Read


Uri Landes, Danny Dvir, Wolfgang Schoels, Christopher Tron, Stephan Ensminger, Matheus Simonato, Ulrich Schäfer, Matjaz Bunc, Gabriel Aldea, Alfredo Cerillo, Stephan Windecker, Antonio Marzocchi, Martin Andreas, Nicolas Amabile, John Webb, Ran Kornowski
AIMS: To evaluate transcatheter aortic valve-in-valve implantation performance in rapid deployment (ViVr) vs. conventional (ViVc) surgical heart valve (SHV). METHODS AND RESULTS: A multicenter registry was developed as part of the VIVID international registry. A total of 30 ViVr [Perceval (Sorin Biomedica, Salugia, Italy), n=24, the ATS 3F Enable (Medtronic Inc., Minneapolis, MN, USA), n=5, and the Intuity (Edwards Lifesciences, Irvine, CA, USA), n=1] were evaluated and compared with 2,288 ViVc patients...
February 19, 2019: EuroIntervention
Marco Barbanti, Martijn S van Mourik, Mark S Spence, Fortunato Icovelli, Gian Luca Martinelli, Douglas F Muir, Francesco Saia, Alessandro Santo Bortone, Cameron G Densem, Frank van der Kley, Peter Bramlage, Marije Vis, Corrado Tamburino
AIMS: Treatment pathway optimization in TAVI should include timely patient discharge with a minimized risk for out-of-hospital adverse events. METHODS AND RESULTS: We defined and validated the adequacy of a set of discharge criteria and their ability to properly predict timely and safe discharge after the intervention in a prospective, European, multicentre registry. 502 unselected patients were enrolled at 10 sites in 3 countries. The primary endpoint defined as a composite of all-cause mortality, vascular-access-related complications, permanent pacemaker implantation, stroke, re-hospitalisation due to cardiac reasons, kidney failure and major bleeding at 30 days was reached in 12...
February 19, 2019: EuroIntervention
Einar A Hart, Sander De Bock, Matthieu De Beule, Arco J Teske, Steven A J Chamuleau, Michiel Voskuil, Adriaan O Kraaijeveld
No abstract text is available yet for this article.
February 19, 2019: EuroIntervention
Sophie Z Gu, Weiliang Qiu, Jonathan A Batty, Hannah Sinclair, Murugapathy Veerasamy, Salvatore Brugaletta, Dermot Neely, Gary Ford, Patrick A Calvert, Gary S Mintz, Vijay Kunadian
AIMS: The association of frailty with coronary plaque phenotype among older patients with non-ST-elevation acute coronary syndrome (NSTEACS) is not known and was evaluated in this study. METHODS AND RESULTS: Older patients with NSTEACS for invasive angiography were recruited. Frailty was measured using Fried Frailty Score. Following angiography, patients underwent grey scale and virtual histology intravascular ultrasound (VH-IVUS). Of the 90 patients, 26 (28.9%) were robust, 49 (54...
February 19, 2019: EuroIntervention
Oscar Cuevas, Raúl Moreno, Virginia Pascual-Tejerina, Stefan Toggweiler, Miriam Brinkert, Jose Baz, Victor Jimenez, Eduardo Molina, Joaquín Sánchez-Gila, Maurizio Taramasso, Fabian Nietlispach
No abstract text is available yet for this article.
February 19, 2019: EuroIntervention
Tawfiq Choudhury, Philipp Lurz, Tim G Schäufele, Miguel Nobre Menezes, Shahar Lavi, Nikolaos Tzemos, Philipp Hartung, Thomas Stiermeier, Katsutoshi Makino, Olivier F Bertrand, Ian C Gilchrist, Mamas A Mamas, Rodrigo Bagur
AIMS: Left ventricular endomyocardial biopsy (LV-EMB) is mostly performed via the femoral artery. We assessed the feasibility and safety of radial versus femoral access in patients undergoing LV-EMB. METHODS AND RESULTS: 264 patients from four countries undergoing LV-EMB were collected. Clinical, procedural, safety and feasibility data were compared between groups. LV-EMB was successfully performed via radial approach in 129 (99%) of 130 and 134 (100%) patients by femoral access...
February 12, 2019: EuroIntervention
Koen Ameloot, Marcelo B Bastos, Joost Daemen, Jan Schreuder, Eric Boersma, Felix Zijlstra, Nicolas M Van Mieghem
AIMS: To establish the value of new generation mechanical circulatory support (MCS) devices such as heartmate PHP (Abott), Impella CP (Abiomed) and PulseCath iVAC2L (Terumo). METHODS AND RESULTS: we retrospectively analyzed all consecutive elective high-risk PCI procedures performed in the Erasmus Medical Center (2011-2018) thereby comparing MCS protected and unprotected patients. The primary end-point was a composite of procedure related adverse events including death (<24 hours), cardiac arrest, need for vasopressors, rescue MCS, endotracheal intubation and limb ischemia with need for surgery...
February 12, 2019: EuroIntervention
Yuki Katagiri, Yoshinobu Onuma, Philipp Lurz, Pawel Buszman, Jan J Piek, Joanna J Wykrzykowska, Taku Asano, Norihiro Kogame, Kuniaki Takahashi, Chun-Chin Chang, Robbert J de Winter, Patrick W Serruys, William Wijns
AIMS: To assess whether the 9 months cytostatic inhibition by crystalline sirolimus has a beneficial effect in the 2-year follow-up in all-comer population undergoing percutaneous coronary intervention. METHODS AND RESULTS: The DESSOLVE III (n=1398) is a prospective, all-comer, multi-centre, randomized controlled study (NCT02385279) allocating 703 patients to receive MiStent drug-eluting stent with a fully absorbable polymer coating containing and embedding a microcrystalline form of sirolimus into the vessel wall and 695 patients to receive Xience durable polymer everolimus-eluting stent...
February 5, 2019: EuroIntervention
Ferit Onur Mutluer, Ömer Yildiz, Alpay Çeliker
No abstract text is available yet for this article.
February 5, 2019: EuroIntervention
Jesse Feiko Veenis, Nicolas M Van Mieghem, Kadir Caliskan, Olivier C Manintveld, Jasper J Brugts
No abstract text is available yet for this article.
February 5, 2019: EuroIntervention
Jinbao Qin, Zhen Zhao, Guang Liu, Kaichuang Ye, Minyi Yin, Chaoyi Cui, Huihua Shi, Zhiyou Peng, Mier Jiang, Xiaobing Liu, Weimin Li, Xinwu Lu
AIMS: The aim of the study was to evaluate the feasibility, safety, and effectiveness of in situ diode laser fenestration of thoracic endovascular aortic repair (TEVAR) stent grafts to treat Stanford type A aortic dissection. METHODS AND RESULTS: 58 patients with acute or subacute Stanford type A aortic dissection treated with in situ diode laser fenestration during TEVAR under cerebral circulation protection with an extracorporeal bypass were reviewed retrospectively...
February 5, 2019: EuroIntervention
Christos V Bourantas, Rodrigo Modolo, Andreas Baumbach, Lars Søndergaard, Bernard D Prendergast, Muhidin Ozkor, Simon Kennon, Anthony Mathur, Michael J Mullen, Patrick W Serruys
Transcatheter aortic valve implantation (TAVI) has rapidly evolved and changed the landscape of structural interventional cardiology. Advances in transcatheter heart valve (THV) prostheses and TAVI enabling devices have simplified the procedure, reduced the risk of complications, improved short- and long-term outcomes and broadened the applications of TAVI not only in challenging patients and complex anatomies but also in intermediate-risk or even in low-risk patients, where surgical valve replacement constitutes an effective and well established therapy...
February 5, 2019: EuroIntervention
Salvatore Cassese, Yuki Katagiri, Robert A Byrne, Salvatore Brugaletta, Fernando Alfonso, Lorenz Räber, Michael Maeng, Andres Iñiguez, Evgeny Kretov, Yoshinobu Onuma, Michael Joner, Manel Sabaté, Karl-Ludwig Laugwitz, Stephan Windecker, Adnan Kastrati, Patrick W Serruys
AIMS: Bioresorbable scaffolds (BRS) were conceived to ensure transient coronary artery support during antiproliferative drug delivery. However, the everolimus-eluting bioresorbable scaffold Absorb (Abbott Vascular, Santa Clara, CA, USA) was found inferior to everolimus-eluting metallic stents (EES) in moderately complex coronary anatomies. We sought to investigate whether the Absorb represents a valuable option for the percutaneous treatment of patients with ST-elevation myocardial infarction (STEMI)...
February 5, 2019: EuroIntervention
Rikuta Hamaya, Masahiro Hoshino, Yoshinori Kanno, Masao Yamaguchi, Hiroaki Ohya, Yohei Sumino, Yoshihisa Kanaji, Eisuke Usui, Tadashi Murai, Tetsumin Lee, Taishi Yonetsu, Kenzo Hirao, Tsunekazu Kakuta
AIMS: Contrast-flow quantitative flow ratio (cQFR) is a novel index of the functional severity of coronary stenosis, which can be calculated from three-dimensional quantitative coronary angiography. Previous studies have shown high correlation between cQFR and fractional flow reserve. This study sought to investigate the prognostic value of the sum of cQFR in three vessels (3V-cQFR) in patients with stable coronary artery disease (CAD). METHODS AND RESULTS: A total of 549 patients who underwent invasive coronary angiography and cQFR measurements in three vessels were analyzed in the present study...
January 29, 2019: EuroIntervention
Ralph Stephan von Bardeleben, Lukas Hobohm, Felix Kreidel, Mir A Ostad, Eberhard Schulz, Stavros Konstantinides, Mareike Lankeit, Ted Feldman, Thomas Münzel, Karsten Keller
AIMS: The number of percutaneous edge-to-edge mitral regurgitation valve repairs with MitraClip® implantation increased during the last years. Published studies showed promising safety outcomes in relatively small cohorts, while results from large samples are sparse. Thus, we aimed to evaluate trends and safety outcomes in the German nationwide inpatient sample. METHODS AND RESULTS: We analyzed data on patients' characteristics and in-hospital safety outcomes for all percutaneous mitral valve repairs in MitraClip® technique in Germany between 2011 and 2015...
January 22, 2019: EuroIntervention
Michael Behnes, Ibrahim Akin, Philipp Kuche, Tobias Schupp, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Ibrahim El-Battrawy, Siegfried Lang, Emmanouil S Brilakis, Lorenzo Azzalini, Alfredo R Galassi, Marouane Boukhris, Hans Neuser, Franz-Joseph Neumann, Christoph Nienaber, Christel Weiß, Martin Borggrefe, Kambis Mashayekhi
AIMS: This study sought to assess the prognostic impact of coronary chronic total occlusions (CTO) in patients presenting with ventricular tachyarrhythmias on admission. METHODS AND RESULTS: A large retrospective registry was used including all consecutive patients presenting with ventricular tachyarrhythmias on admission and undergoing coronary angiography from 2002 to 2016. Patients with a CTO were compared with all other patients (non-CTO) for prognostic outcomes...
January 22, 2019: EuroIntervention
Stefan Verheye, Adrian Wlodarczak, Piero Montorsi, Johan Bennett, Jan Torzewski, Michael Haude, Mathias Vrolix, Thomas Buck, Adel Aminian, Rene J van der Schaaf, Amin Arrif Nuruddin, Michael K Y Lee
No abstract text is available yet for this article.
January 22, 2019: EuroIntervention
Ole De Backer, Jacob Lønborg, Steffen Helqvist, Julie Warnøe, Lene Kløvgaard, Lene Holmvang, Frants Pedersen, Hans-Henrik Tilsted, Bent Raungaard, Erik Jørgensen, Lars Køber, Dan Eik Høfsten, Henning Kelbæk, Thomas Engstrøm
AIMS: Treatment of the infarct-related artery only (IRA-only) in ST-segment elevation myocardial infarction (STEMI) is associated with a significantly higher rate of ischemia-driven revascularization (ID-RV) during follow-up than fractional flow reserve-guided complete revascularization (FFR-CRV). METHODS AND RESULTS: In this study, we characterized the lesions that underwent ID-RV in the DANAMI-3-PRIMULTI-trial (n=627) with respect to location, angiographic diameter stenosis and functional significance...
January 22, 2019: EuroIntervention
Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, Fernando Alfonso, Adrian P Banning, Umberto Benedetto, Robert A Byrne, Jean-Philippe Collet, Volkmar Falk, Stuart J Head, Peter Jüni, Adnan Kastrati, Akos Koller, Steen D Kristensen, Josef Niebauer, Dimitrios J Richter, Petar M Seferović, Dirk Sibbing, Giulio G Stefanini, Stephan Windecker, Rashmi Yadav, Michael O Zembala
No abstract text is available yet for this article.
January 15, 2019: EuroIntervention
Ruka Yoshida, Hideki Ishii, Itsuro Morishima, Akihito Tanaka, Kensuke Takagi, Naoki Iwakawa, Hiroshi Tashiro, Hiroki Kojima, Takayuki Mitsuda, Kenshi Hirayama, Yusuke Hitora, Kenji Furusawa, Toyoaki Murohara
AIMS: Although drug-coated balloon (DCB) angioplasty can be an alternative therapy for in-stent restenosis and small-vessel disease, recurrent target lesion failure still accounts up to 20%. We aimed to investigate whether the adjunctive use of guide extension catheter (GEC) may enhance the efficacy of DCB. METHODS AND RESULTS: We performed a before-and-after cohort study including patients undergoing DCB angioplasty. We treated 83 patients with 93 lesions who underwent conventional DCB angioplasty and 79 patients with 94 lesions who underwent DCB angioplasty with adjunctive use of GEC...
January 15, 2019: EuroIntervention
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"